Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153373 · ClinicalTrials.gov registry record · Phase 2
Dynamic Assessment and Referral System - Evaluation
A Phase 2 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 2
- Development phase
- 758
- Enrollment target
NCT01153373 is a Phase 2 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 758 participants.
The verdict
NCT01153373, a Phase 2 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 758 participants
- Enrollment target
Study Summary
The investigators study will use a randomized controlled design. Eligible and consenting participants will be randomly assigned to one of two conditions: (1) DARSSA Intervention condition, or (2) Minimal Intervention Control condition. All enrolled participants will undergo the DARSSA baseline assessment and will be interviewed immediately following their ED discharge to assess relevant outcomes, such as whether they were asked about substance use and given a referral during their visit. This is referred to as the post-visit interview. All risky substance users enrolled during all phases will be interviewed again at 1- and 3-months post-visit to assess substance use, treatment engagement, and other outcomes. The primary difference between the two conditions is that, for the DARSSA Intervention condition, the subjects will have their reports printed and will be given the option of receiving the dynamic referral, while for the Minimal Intervention Control condition the subjects will undergo the assessment and will receive the standard substance abuse treatment referral list currently in use clinically at each site. The number of assessments and interactions with research staff will remain equal between the two conditions, with the only difference being the active intervention of the DARSSA reports and referrals, and any counseling by healthcare providers this engenders. The remainder of this section describes each phase of the study and enrollment procedures.
Interventions
- BEHAVIORAL Self-administered computerized assessment for tobacco, substance abuse, and alcohol use.
- BEHAVIORAL Self-Administered Computerized Assessment and Counseling for Tobacco, Alcohol, and Substance Abuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 758 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153373
The ClinicalTrials.gov registry entry for NCT01153373 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 758 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self-administered computerized assessment for tobacco, substance abuse, and alcohol use. is the first listed.
NCT01153373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01153373 about?
NCT01153373 is a clinical study titled "Dynamic Assessment and Referral System - Evaluation". The investigators study will use a randomized controlled design. Eligible and consenting participants will be randomly assigned to one of two conditions: (1) DARSSA Intervention condition, or (2) Minimal Intervention Control condition. All enrolled participants will undergo the DARSSA baseline asses...
What is the current status of trial NCT01153373?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 758 participants. The study started on 2010-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01153373?
The interventions under investigation include: Self-administered computerized assessment for tobacco, substance abuse, and alcohol use. (BEHAVIORAL), Self-Administered Computerized Assessment and Counseling for Tobacco, Alcohol, and Substance Abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT01153373?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.